Cargando…

Istaroxime, a potential anticancer drug in prostate cancer, exerts beneficial functional effects in healthy and diseased human myocardium

The current gold standard for prostate cancer treatment is androgen deprivation therapy and antiandrogenic agents. However, adverse cardiovascular events including heart failure can limit therapeutic use. Istaroxime, which combines Na(+)-K(+)-ATPase (NKA) inhibition with sarco/endoplasmic reticulum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wallner, Markus, Khafaga, Mounir, Kolesnik, Ewald, Vafiadis, Aris, Schwantzer, Gerold, Eaton, Deborah M., Curcic, Pero, Köstenberger, Martin, Knez, Igor, Rainer, Peter P., Pichler, Martin, Pieske, Burkert, Von Lewinski, Dirk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564766/ https://www.ncbi.nlm.nih.gov/pubmed/28514771 http://dx.doi.org/10.18632/oncotarget.17540

Ejemplares similares

Cellular Mechanisms Underlying the Low Cardiotoxicity of Istaroxime
por: Racioppi, María Florencia, et al.
Publicado: (2021)

Impact of the SGLT2-inhibitor empagliflozin on inflammatory biomarkers after acute myocardial infarction – a post-hoc analysis of the EMMY trial
por: Benedikt, Martin, et al.
Publicado: (2023)

Istaroxime: A rising star in acute heart failure
por: Aditya, Suruchi, et al.
Publicado: (2012)

The Anti-Cancer Multikinase Inhibitor Sorafenib Impairs Cardiac Contractility by Reducing Phospholamban Phosphorylation and Sarcoplasmic Calcium Transients
por: Schneider, Christopher, et al.
Publicado: (2018)

Efficacy of the New Inotropic Agent Istaroxime in Acute Heart Failure
por: Forzano, Imma, et al.
Publicado: (2022)

miR-1183 Is a Key Marker of Remodeling upon Stretch and Tachycardia in Human Myocardium
por: Djalinac, Natasa, et al.
Publicado: (2022)

Alterations in trimethylamine-N-oxide in response to Empagliflozin therapy: a secondary analysis of the EMMY trial
por: Aziz, Faisal, et al.
Publicado: (2023)

New Antihyperglycemic Drugs and Heart Failure: Synopsis of Basic and Clinical Data
por: von Lewinski, Dirk, et al.
Publicado: (2017)

Thermic sealing in femoral catheterization: First experience with the Secure Device
por: Sacherer, Michael, et al.
Publicado: (2019)

Effects of BNP and Sacubitrilat/Valsartan on Atrial Functional Reserve and Arrhythmogenesis in Human Myocardium
por: Primessnig, Uwe, et al.
Publicado: (2022)

Staphylococcus lugdunensis Endocarditis in a 35-Year-Old Woman in Her 24th Week of Pregnancy
por: Khafaga, Mounir, et al.
Publicado: (2016)

Istaroxime treatment ameliorates calcium dysregulation in a zebrafish model of phospholamban R14del cardiomyopathy
por: Kamel, S. M., et al.
Publicado: (2021)

Safety and Efficacy of Istaroxime in Patients With Acute Heart Failure: A Meta-Analysis of Randomized Controlled Trials
por: Khalid Khan, Saad, et al.
Publicado: (2023)

Incidence, predictors, and prognosis of premature discontinuation or switch of prasugrel or ticagrelor: the ATLANTIS - SWITCH study
por: Winter, Max-Paul, et al.
Publicado: (2019)

SGLT2 Inhibitors and Their Antiarrhythmic Properties
por: Kolesnik, Ewald, et al.
Publicado: (2022)

Impaired Relaxation and Reduced Lusitropic Reserve in Atrial Myocardium in the Obese Patients
por: Wen, Yan, et al.
Publicado: (2021)

SERCA2a stimulation by istaroxime improves intracellular Ca(2+) handling and diastolic dysfunction in a model of diabetic cardiomyopathy
por: Torre, Eleonora, et al.
Publicado: (2021)

Evaluation of the Anticancer and Biological Activities of Istaroxime via Ex Vivo Analyses, Molecular Docking and Conceptual Density Functional Theory Computations
por: Gok, Ege, et al.
Publicado: (2023)

Timing of SGLT2i initiation after acute myocardial infarction
por: von Lewinski, Dirk, et al.
Publicado: (2023)

Limiting factors for wearing personal protective equipment (PPE) in a health care environment evaluated in a randomised study
por: Loibner, Martina, et al.
Publicado: (2019)

Left ventricular ejection fraction and cardiac biomarkers for dynamic prediction of cardiotoxicity in early breast cancer
por: Posch, Florian, et al.
Publicado: (2022)

The prevalence of meibomian gland dysfunction, tear film and ocular surface parameters in an Austrian dry eye clinic population
por: Rabensteiner, Dieter Franz, et al.
Publicado: (2018)

Successful Two-Stage Exchange Arthroplasty for Periprosthetic Infection Following Total Knee Arthroplasty: The Impact of Timing on Eradication of Infection
por: Vielgut, Ines, et al.
Publicado: (2021)

Platelet reactivity patterns in patients treated with dual antiplatelet therapy
por: Winter, Max‐Paul, et al.
Publicado: (2019)

Revisiting the Diabetes-Heart Failure Connection
por: Wallner, Markus, et al.
Publicado: (2018)

A biopsychosocial model of severe fear of COVID-19
por: Nürnberger, Patrick, et al.
Publicado: (2022)

Ticagrelor and prasugrel are independent predictors of improved long‐term survival in ACS patients
por: Gager, Gloria M., et al.
Publicado: (2020)

Outcomes of ECLS-SHOCK Eligibility Criteria Applied to a Real-World Cohort
por: von Lewinski, Dirk, et al.
Publicado: (2023)

The Fold Variant BM4 Is Beneficial in a Therapeutic Bet v 1 Mouse Model
por: Pichler, Ulrike, et al.
Publicado: (2013)

Functional characterization and anti-cancer action of the clinical phase II cardiac Na(+)/K(+) ATPase inhibitor istaroxime: in vitro and in vivo properties and cross talk with the membrane androgen receptor
por: Alevizopoulos, Konstantinos, et al.
Publicado: (2016)

Floppy interatrial septum mimicking an ASD: The role of left atrial pressure
por: Zach, Veronika, et al.
Publicado: (2021)

Safety and efficacy of istaroxime in patients with acute heart failure‐related pre‐cardiogenic shock – a multicentre, randomized, double‐blind, placebo‐controlled, parallel group study (SEISMiC)
por: Metra, Marco, et al.
Publicado: (2022)

Cohort profile: ‘Biomarkers of Personalised Medicine’ (BioPersMed): a single-centre prospective observational cohort study in Graz/Austria to evaluate novel biomarkers in cardiovascular and metabolic diseases
por: Haudum, Christoph Walter, et al.
Publicado: (2022)

Tuberculoma of the Myocardium
por: Wahi, P. N., et al.
Publicado: (1951)

Necrosis of the Myocardium
por: Rogers, Herbert
Publicado: (1931)

PRospective REgistry of PAtients in REfractory cardiogenic shock—The PREPARE CardShock registry
por: von Lewinski, Dirk, et al.
Publicado: (2022)

A High-Cholesterol Diet Increases Toll-like Receptors and Other Harmful Factors in the Rabbit Myocardium: The Beneficial Effect of Statins
por: Kapelouzou, Alkistis, et al.
Publicado: (2021)

Diabetic Cardiomyopathy: Current and Future Therapies. Beyond Glycemic Control
por: Borghetti, Giulia, et al.
Publicado: (2018)

Increased mortality and worse cardiac outcome of acute myocardial infarction during the early COVID‐19 pandemic
por: Primessnig, Uwe, et al.
Publicado: (2020)

The Impact of Visual Guided Order Picking on Ocular Comfort, Ocular Surface and Tear Function
por: Klein-Theyer, Angelika, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_h0hg3fo7lkdbqu7qjsus3aerlr